Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/

Accepted 2021-07-15 00:00:00 ET · period of report 2021-07-13 · accession 0001209191-21-046791 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-07-15	2021-07-13	HRTX	Szekeres David Leslie	EVP, COO	M - OptEx	—	+1,250	3,597	+53%	—
D	2021-07-15	2021-07-13	HRTX	Szekeres David Leslie	EVP, COO	F - Tax	$13.48	-433	3,164	-12%	-$5,837
D	2021-07-15	2021-04-30	HRTX	Szekeres David Leslie	EVP, COO	J - Other	$13.90	+1,530	2,347	+187%	+$21.3K
D	2021-07-15	2021-07-13	HRTX	Szekeres David Leslie	EVP, COO	M - OptEx	$0.00	-1,250	16.2K	-7%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-07-13	M	A	1,250	—	3,597	D	—	—	(F2) Restricted stock units convert into common stock on a one-for-one basis.
2	Common	Common Stock	2021-07-13	F	D	433	$13.48	3,164	D	—	—	(F3) Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
3	Common	Common Stock	2021-04-30	J	A	1,530	$13.90	2,347	D	—	—
4	Derivative	Restricted Stock Units	2021-07-13	M	D	1,250	$0.00	16,250	D	— · — to —	1,250 Common Stock	(F2) Restricted stock units convert into common stock on a one-for-one basis. (F4) The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020).